Daivonex, ointment 50 mcg/g 30 g
€36.93 €30.77
Pharmacodynamics
The drug for the treatment of psoriasis.
Calcipotriol is a synthetic analog of the active metabolite of vitamin D , stimulates morphological differentiation and inhibits proliferation of keratinocytes, which underlies its therapeutic effect in psoriasis.
Calcipotriol is a potent inhibitor of interleukin I-induced T-lymphocyte activation.
The effect of calcipotriol on calcium metabolism is 100 times weaker than vitamin D3.
Pharmacokinetics
The transdermal absorption of calcipotriol is, depending on the dose used, 1% to 5%. Calcipotriol undergoes rapid biotransformation in the liver to form pharmacologically inactive metabolites. T 1/2 is very short.
Indications
Psoriasis vulgaris, including chronic psoriasis of the scalp.
Active ingredient
Composition
Active ingredient:
Calcipotriol 50 µg.
Associates:
dinatrium edetate,
sodium hydrophosphate,
α-tocopherol,
liquid paraffin,
polyethylene glycol stearate,
propylene glycol,
white paraffin,
water.
How to take, the dosage
The ointment is applied in a thin layer to the affected areas of the skin 2 times a day. Therapeutic effect is usually observed after 1-2 weeks of treatment. The duration of the course of treatment is not more than 6-8 weeks.
Interaction
Diveonex should not be used at the same time as topical medications containing salicylic acid.
Special Instructions
It is not recommended to apply the ointment to the skin of the face.
To avoid contact of the drug with the skin of the face, hands should be thoroughly washed after each application of the ointment.
Hypercalcemia develops when the maximum dose of calcipotriol is exceeded in a week. When the drug is discontinued, the calcium concentration in the blood quickly normalizes.
The treatment with Daivonex can be combined with PUVA therapy.
Impact on ability to drive vehicles and other mechanisms requiring increased concentration
Dyvonex does not affect the ability to drive vehicles and operate machinery.
Contraindications
With caution, use the drug in: hypercalcemia, hypercalciuria, hypervitaminosis D, nephrolithiasis. In children in case of lack of experience. In patients over 65 years of age.
Side effects
Dermatological reactions: local skin irritation, erythema and skin itching are possible; dermatitis, exacerbation of psoriasis is rare; in some cases – hyperpigmentation, photosensitization.
Metabolism: hypercalciuria, hypercalcemia.
Overdose
Symptoms: if the drug is used in doses higher than recommended, the blood calcium concentration may increase.
Treatment: discontinue the drug.
Pregnancy use
The safety of the drug during pregnancy and lactation has not been established.
It is unknown whether calcipotriol is excreted with breast milk.
Weight | 0.050 kg |
---|---|
Shelf life | 2 years. |
Conditions of storage | Store at a temperature not exceeding 25°C. Keep out of reach of children. |
Manufacturer | LEO Laboratories Limited, Ireland |
Medication form | topical ointment |
Brand | LEO Laboratories Limited |
Related products
Buy Daivonex, ointment 50 mcg/g 30 g with delivery to USA, UK, Europe and over 120 other countries.